Myopia - 71 Studies Found
Completed |
: Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia : Pathological Myopia : 2010-10-06 :
|
Completed |
: A Randomized, Double-blind, Multicenter, Sham-controlled, Safety and Efficacy Study of Conbercept in Patients With mCNV : Choroid Neovascularization Secondary to Degenerative Myopia : 2013-03-11 :
|
Completed |
: Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD) :
: Drug: Bevacizumab |
Recruiting |
: Ocular Discomfort Assessment After Intravitreal Injections :
|
Recruiting |
: Pharmacogenomic Study on Anti-VEGF Medicine in Treatment of Macular Neovascular Diseases :
|
Recruiting |
: Dosing Strategy of Intravitreal Ranibizumab for Pathological Myopia Choroidal Neovascularization : Choroidal Neovascularization : 2016-08-21 : Drug: 0.5mg intravitreal ranibizumab Patients received ranibizumab (0.5mg, Novartis AG, Basel, Switzerla |
Completed |
: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy :
|
Completed |
: VEGF Trap-Eye in Choroidal Neovascularization Secondary to Pathologic Myopia (mCNV) : Myopia, Pathological : 2010-11-26 :
|
Completed |
: A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia. : Choroidal Neovascularization Secondary to Pathologic Myopia : 2014-01-09 : Drug: Ranibizumab All patients will receive a single initial intravitreal injection of ranibizumab 0.5 m |